Phase I trial of autologous NK cell immunotherapy combined with chemotherapy in patients with recurrent epithelial ovarian cancer

2019 ◽  
Vol 154 ◽  
pp. 266-267
Author(s):  
W.D. Joo
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Epithelial Ovarian Cancer ◽  
Phase I Trial ◽  
Nk Cell ◽  
Cell Immunotherapy

Abstract B273: A phase I trial of topotecan and sorafenib for patients with recurrent, platinum‐resistant epithelial ovarian cancer

2009 ◽  
Author(s):  
Daniela E. Matei ◽  
Jeanne Schilder ◽  
Susan Perkins ◽  
Mohammad Khan ◽  
Cynthia Calley ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Epithelial Ovarian Cancer ◽  
Phase I Trial ◽  
Platinum Resistant

scholarly journals A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer

2015 ◽  
Vol 26 (10) ◽  
pp. 2141-2149 ◽  
Author(s):  
E.M. Dijkgraaf ◽  
S.J.A.M. Santegoets ◽  
A.K.L. Reyners ◽  
R. Goedemans ◽  
M.C.A. Wouters ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Monoclonal Antibody ◽  
Phase I ◽  
Epithelial Ovarian Cancer ◽  
Phase I Trial ◽  
Interferon Α2b

scholarly journals Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience

Oncotarget ◽  
2016 ◽  
Vol 7 (23) ◽  
pp. 35132-35143 ◽  
Author(s):  
Ming-Mo Hou ◽  
Zhijie Wang ◽  
Filip Janku ◽  
Sarina Piha-Paul ◽  
Aung Naing ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Epithelial Ovarian Cancer ◽  
Tumor Progression ◽  
Phase I Trial ◽  
High Grade ◽  
Angiogenic Therapy ◽  
Trial Experience
Sign in / Sign up

Export Citation Format

Share Document